Quinolone antibacterials: A new class of photochemical carcinogens

Journal of Photochemistry and Photobiology B: Biology

Volumn 37, Issue 3, 1997, Pages 182-187

  Mäkinen, Markus ^a   Forbes, P Donald ^b   Stenbäck, Frej ^a  

^a UNIVERSITY OF OULU   (Finland)

^b Argus Research Laboratories Inc   (United States)

Author keywords

Photochemical carcinogens; Quinolone antibacterials

Indexed keywords

CARCINOGEN; CIPROFLOXACIN; FLEROXACIN; LOMEFLOXACIN; METHOXSALEN; NALIDIXIC ACID; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; KERATOSIS; MOUSE; NONHUMAN; PAPILLOMA; PHOTOCHEMISTRY; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET A RADIATION;

ANIMALS; ANTI-INFECTIVE AGENTS; CARCINOMA, SQUAMOUS CELL; CIPROFLOXACIN; DERMATITIS, PHOTOTOXIC; FLEROXACIN; FLUOROQUINOLONES; METHOXSALEN; MICE; MICE, INBRED HRS; NALIDIXIC ACID; NEOPLASMS, RADIATION-INDUCED; OFLOXACIN; PAPILLOMA; QUINOLONES; SKIN NEOPLASMS;

EID: 0031081540     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(96)07425-8     Document Type: Article

References (30)

1. [1] C. Siporin, C.L. Heifetz and J.M. Domagala, The New Generation of Quinolones, Dekker, New York, 1990, p. 347.
2. [2] T. Rosen, The fluoroquinolone antibacterial agents, Prog. Med. Chem., 27 (1990) 235-295.
3. [3] C.P. Kirby, Treatment of simple urinary tract infections in general practice with a 3-day course of norfloxacin, J. Antimichrob. Chemother. Suppl. B, 13 (1984) 107-112.
4. [4] D. Adam, Use of quinolones in pediatric patients, Rev. Resp. Dis., 11 (5) (1989) 113-116.
5. [5] S.M. Douidar and W.R. Snodgrass, Potential role of fluoroquinolones in pediatric infections, Rev. Infect. Dis., 11 (6) (1989) 878-889.
6. [6] W. Christ, T. Lehnert and B. Ulbrich, Specific toxicologic aspects of quinolones, Rev. Infect. Dis. 10 (1988) 144-146.
7. [7] P. Schacht, G. Arcieri and R. Hullmann, Safety of ciprofloxacin, Am. J. Med., 87 (5A) (1989) 98S-102S.
8. [8] R. Stahlmann, Safety profile of quinolones, J. Antimichrob. Chemother. D, 26 (1990) 31-44.
9. [9] A.W. Gough, O.B. Kasali, R.E. Sigler and V. Baragi, Quinolone arthropathy-acute toxicity to immature articular cartilage, Toxicol. Pathol., 20 (1992) 436-449.
10. [10] N. Wagai, F. Yamaguchi, M. Sekiguchi and K. Tawara, Phototixic potential of quinolone antibacterial agents in Balb/c mice, Toxicol. Lett., 54 (1990) 299-308.
11. [11] N. Wagai and K. Tawara, Quionolone antibacterial agents-induced cutaneous phototoxicity. Ear swelling reactions in Balb/c mice, Toxicol. Lett., 58 (1991) 215-223.
12. [12] N. Wagai and K. Tawara, Important role of oxygen metabolites in quinolone antibacterial agent-induced cutaneous phototoxicity in mice, Arch. Toxicol., 65 (1991) 495-499.
13. [13] World Health Organization, Int. Agency Res. Cancer Mono. Eval. Carcinogen. Risk Chem. Humans, Ultraviolet Radiat., 40 (1986).
14. [14] World Health Organization, Int. Agency Res. Cancer Mono. Ser. Ultraviolet Radiat., 56 (1992) 1-316.
15. [15] H.V. Van Weelden, S.C.J. van der Putte, J. Toonstra and J.C. van der Leun, UVA-induced tumours in pigmented hairless mice and the carcinogenic risk of tanning with UVA, Arch Dermatol. Res. 282 (1990) 289-294.
16. [16] B.E. Johnson, N.K. Gibbs and J. Ferguson, A quinolone antibiotic with potential to photosensitize skin tumorigenesis, J. Photochem. Photobiol. B, in press.
17. [17] F. Urbach, Phototoxicity and possible enhancement of photcarcinogensis by fluorinated quinolone antibiotics, J. Photochem. Photobiol. B, in press.
18. [18] G. Klecak, F. Urbach and H. Urwyler, Fluoroquinolone antibacterials enhance UVA-enduced skin tumors, J. Photochem. Photobiol. B, in press.
19. [19] F. Stenbäck. Cell injury and cell proliferation in skin carcinogenesis induced by UV light, Oncology, 31 (1975) 61-75.
20. [20] F. Stenbäck, Species-specific neoplastic progression by ultraviolet light on the skin of rats, guinea pigs, hamsters and mice, Oncology, 31 (1975) 209-212.
21. [21] F. Stenbäck, Life history and histopathology of ultraviolet light-induced skin tumors, Nat. Cancer Inst. Mono., 50 (1978) 57-70.
22. [22] F. Stenbäck, Promotion in the morphogenesis of chemically inducible skin tumors, Acta Path. Microbiol. Scand. Suppl., 208 (1969) 1-116.
23. [23] F. Stenbäck, Characteristics of neoplastic progression and tumor behavior in skin carcinogenesis by different methods, Oncology, 37 (1980) 163-168.
24. [24] Lever and Schaumburg-Lever, Histopathology of the Skin, 7th edn., J.B. Lippincott, 1991.
25. [25] J.H. Epstein and W.L. Epstein, A study of tumor types produced by ultraviolet light in hairless and hairy mice, J. Invest. Dermatol., 41 (1963) 463-473.
26. [26] R.K. Winkelmann, E.J. Baldes and P.E. Zollman, Squamous cell tumors induced in hairless mice with ultraviolet light, J. Invest. Dermatol., 34 (1960) 131-138.
27. [27] R. Mark, P. Forbes, C.P. Sambuco, R.E. Davies and K.L. Gabriel, Comparative histopathologic appearance of UV-induced skin tumors in hairless mice, chryptotrix mice, and fuzzy rats, J. Toxicol. Cutan. Ocular Toxicol., 9(2) (1989-1990) 525-537.
28. [28] World Health Organization, Environ. Health Crit. Ultraviolet Radiat., 14 (1919) 1-110.
29. [29] M. Hannuksela, F. Stenbäck and A. Lahti, The carcinogenic properties of UVA. A lifelong study in mice, Arch. Dermatol. Res., 278 (1986) 347-341.
30. [30] J.K. Dunnick, D. Forbes, S.L. Eustis, J.F. Hardistry and D.G. Goodman, Tumors of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiation, Fund. Appl. Toxicol., 1 (1990) 92-102.